Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages en Stemming true Single Family Member true

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents

Full Query

IC:A61K33/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.20200352986METHODS AND COMPOSITIONS FOR ALLEVIATING RESPIRATORY DYSFUNCTION
US 12.11.2020
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No 16936036 Applicant Shawn J. Green Inventor Shawn J. Green

Compositions, methods of manufacturing compositions, methods of protecting against respiratory problems including coronavirus and coronavirus-associated severe acute respiratory syndrome (SARS) in humans and animals, are provided. Compositions comprising inorganic nitrate used for improving nitric oxide levels, improving health and/or reducing symptoms of SARS are provided. The compositions and methods are applicable for subjects experiencing SARS, and for protecting non-infected subjects against SARS. Compositions and methods for improving nitric oxide levels in a subject disclosed herein comprise administration of compositions comprising inorganic nitrate such as potassium nitrate or sodium nitrate optionally combined with ascorbate.

2.3141249PHARMACEUTICAL COMPOSITION FOR TREATING A GLYCOPROTEIN-RELATED DISEASE
EP 15.03.2017
Int.Class A61K 31/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
095Sulfur, selenium or tellurium compounds, e.g. thiols
10Sulfides; Sulfoxides; Sulfones
Appl.No 16184199 Applicant LU MING CHANG Inventor LU MING-CHANG
A method for treating a glycoprotein-related disease is disclosed, which comprises: administering a first effective amount of phenol red and a second effective amount of an organic arsenic compound to a subject in need thereof.
3.111228464Broad-spectrum coronavirus resistant polypeptide and purpose thereof
CN 05.06.2020
Int.Class A61K 38/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
Appl.No 202010129677.0 Applicant SHANGHAI VETERINARY RESEARCH INSTITUTE, CHINESE ACADEMY OF AGRICULTURAL SCIENCES (CHINA CENTER FOR ANIMAL HEALTH AND EPIDEMIOLOGY, SHANGHAI BRANCH) Inventor SHAN TONGLING
The invention provides a broad-spectrum coronavirus resistant medicine based on a PABPC4 protein. Based on the PABPC4 protein, various coronavirus N proteins can be combined and degraded, the overexpression of a PABPC4 gene can restrain duplication and propagation of voronaviruses, SP1 transcription factors can directly adjust and control transcription of the PABPC4 gene, and the PABPC4 protein, MARCH8 and NDP52 interact, so that the action mechanism of coronavirus N protein is degraded through a PABPC4-MARCH8-NDP52 selectivity autophagy way. The invention provides a broad-spectrum coronavirusresistant medicine or a medicine for treating diseases caused by various coronaviruses including 2019 novel coronaviruses.
4.101085811SARS coronavirus pharmaceutical target and application thereof
CN 12.12.2007
Int.Class C07K 14/165
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
165Coronaviridae, e.g. avian infectious bronchitis virus
Appl.No 200610027476.X Applicant Shanghai Institutes for Biological Sciences, CAS Inventor Sun Bing
The invention relates to a medicinal target point for SARS coronavirus and its application. The medicinal target point is protein coded by ORF3a virus gene, possesses ion channel property, the amnio acid squence is SEQ ID NO: 1 or its derivant aquence. The invention aslo provides the monoclonal antibody and multiple antibody of said medicinal target point and the preparation method, and a kind of inhibitive agent for virus.
5.111471105Preparation and application of silver therapy neutralizing antibody for treating 2019-nCoV
CN 31.07.2020
Int.Class C07K 16/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
08against material from viruses
10from RNA viruses
Appl.No 202010369388.8 Applicant GUANGXI MEDICAL UNIVERSITY Inventor ZHAO YONGXIANG
The invention belongs to the field of medicines, and particularly relates to a silver therapy neutralizing antibody for treating 2019-nCoV, which is a composite nanomaterial containing Ag NPs-Ab, wherein Ag NPs represent nano-silver particles; Ab represents an anti-novel coronavirus monoclonal antibody, the Ag NPs-Ab composite nanomaterial is prepared, Ag NPs are transported to a 2019-nCoV novel coronavirus infected part in a targeted mode, the uptake effect of virus cells on nanoparticles is improved, by means of the biological toxicity of Ag nanoparticles, therefore, the treatment effect on2019-nCoV novel coronavirus virus patients is realized, and the antibody has the characteristics of antiviral property, strong bactericidal effect, strong permeability, no drug resistance and the like, is successfully tested on mice and can be applied to clinical tests of human body anti-novel coronavirus virus in the next step, and a good method is provided for clinical use of human body anti-novel coronavirus virus.
6.20200281972COPPER ION COMPOSITIONS AND METHODS OF TREATMENT FOR CONDITIONS CAUSED BY CORONAVIRUS AND INFLUENZA
US 10.09.2020
Int.Class A61K 33/34
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
34Copper; Compounds thereof
Appl.No 16881937 Applicant CDA Research Group, Inc. Inventor ChunLim ABBOTT

Provided herein are formulations containing copper ions and methods of treating underlying infections and conditions caused by coronavirus, particularly COVID-19, and influenzas, particularly influenza A and/or influenza B using such formulations. Methods of treating the underlying viruses and their resultant conditions using topical copper ion treatments are provided. A topical treatment in its basic form comprises a biocompatible copper ion solution or suspension obtained by leaching of the copper ions from copper metal. The copper ion solution or suspension may be combined with various carriers to form the copper ion treatment including creams or solutions. Methods of making the copper ion solution or suspension from solid copper metal in a biocompatible solution are also provided.

7.2004359653METHOD FOR TREATMENT AND PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) WITH DEUTERIUM-DECREASED WATER (SUPERLIGHT WATER)
JP 24.12.2004
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No 2003193198 Applicant INTERNATL SCIENT:KK Inventor USUI TATSUO

PROBLEM TO BE SOLVED: To provide an effective method for the treatment and prevention of severe acute respiratory syndrome (SARS) to which effective treatment is not yet developed and the present treatment is the transfer to a hospital to leave a patient to spontaneous healing and for which preventing method is lacked except for the wearing of mask, washing of hands, gargling, sterilization, or the like.

SOLUTION: Severe acute respiratory syndrome (SARS) is treated and prevented by enhancing immunological competence by lowering the heavy water concentration in the body by using a deuterium-decreased water (superlight water).

COPYRIGHT: (C)2005,JPO&NCIPI

8.20200261496Method of treating and/ or preventing viral infection.
US 20.08.2020
Int.Class A61K 33/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
Appl.No 16825441 Applicant Vladimir Oks Inventor Vladimir Oks

A method of treating and/or preventing viral infections including common cold, influenza, and coronaviruses with or without symptoms is based on a fact that virus's survival time depends on the temperature and relative humidity, and an assumption that a virus can be killed or its ability to penetrate and replicate copies inside living cells can be weakened, by prolonged exposure to such environment, which can be controlled by an individual. Creating such environment in the upper respiratory and gastrointestinal (GI) tracts and preventing spread of the virus into the lower part of the respiratory tract using continuous and prolonged heat exposure on the virus, prevents development of pneumonia.

9.WO/2005/074990METHODS OF PREVENTING AND TREATING SARS USING LOW PH RESPIRATORY TRACT COMPOSITIONS
WO 18.08.2005
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/US2005/003172 Applicant THE PROCTER & GAMBLE COMPANY Inventor RENNIE, Paul, John
The present invention is directed to methods of preventing and treating Severe Acute Respiratory Syndrome (SARS) by the administration of respiratory tract compositions having low pH values. The respiratory tract compositions have a pH of from about 3.0 to about 5.5, and are preferably administered to areas of the respiratory tract such as the nasal cavity to effectively prevent and treat respiratory tract viral infections, particularly SARS. The respiratory tract compositions comprise an organic acid in combination with a metal compound.
10.110870402Prescription capable of treating pneumonia caused by 2019-nCoV (a novel coronavirus) infection and application thereof
CN 06.03.2020
Int.Class A61K 36/9068
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
88Liliopsida (monocotyledons)
906Zingiberaceae (Ginger family)
9068Zingiber, e.g. garden ginger
Appl.No 202010081961.5 Applicant GE YOUWEN Inventor GE YOUWEN
The invention relates to traditional Chinese medicine compositions, and specifically discloses a prescription capable of treating pneumonia caused by 2019-nCoV (a novel coronavirus) infection as wellas application thereof. The prescription capable of treating the pneumonia caused by the 2019-nCoV infection comprises the following traditional Chinese medicine materials as raw materials in parts byweight: 9 parts of ephedra, 6 parts of roasted liquorice roots, 9 parts of apricot kernels, 15-30 parts of raw gypsum, 9 parts of cassia twigs, 9 parts of oriental waterplantain rhizome, 9 parts of zhuling, 9 parts of white atractylodes rhizomes, 15 parts of poria cocos, 16 parts of radix bupleuri, 6 parts of baical skullcap roots, 9 parts of ginger processed pinellia tubers, 9 parts of fresh ginger, 9 parts of aster, 9 parts of common coltsfoot flowers, 9 parts of blackberry lily rhizome, 6 parts of manchurian wildginger, 12 parts of Chinese yams, 6 parts of immature orange fruits, 6 parts of dried orange peel, and 9 parts of wrinkled gianthyssop herb. In combination with symptom manifestation of the pneumonia caused by the 2019-nCoV infection, the invention adopts an optimized and integrated traditional Chinese medicine prescription, thereby achieving synergistic treatment effects. According to current treatment results of diagnosed patients of different ages in many provinces and regions, the prescription capable of treating the pneumonia caused by the 2019-nCoV infection has true curative effects that the response rate is up to 95.12%.